EGFR+ Non–Small Cell Lung Cancer: Frontline Options
2 Views
administrator
07/04/23
Expert Mark Socinski, MD, shares insight on the frontline systemic therapy options available for EGFR-mutant non–small cell lung cancer treatment and considers the value of multidisciplinary care in the context of brain metastases.
For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/
-
Category
Show more
Facebook Comments
No comments found